Control of hypertension and dyslipidemia among patients with hypertension with and without metabolic syndrome, diabetes, and cardiovascular disease

被引：0
|
作者：
Wong, ND
Pio, JR
Franklin, SS
Tang, S
Williams, GR
机构：
[1] Univ Calif Irvine, Irvine, CA USA
[2] Pfizer Pharmaceut Inc, New York, NY USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3173
引用
收藏
页码：U741 / U741
页数：1
相关论文
共 50 条
  • [31] Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment
    Alfredo Halpern
    Marcio C Mancini
    Maria Eliane C Magalhães
    Mauro Fisberg
    Rosana Radominski
    Marcelo C Bertolami
    Adriana Bertolami
    Maria Edna de Melo
    Maria Teresa Zanella
    Marcia S Queiroz
    Marcia Nery
    Diabetology & Metabolic Syndrome, 2
  • [32] Perceptions of hypertension treatment among patients with and without diabetes
    Heymann Anthony
    Liora Valinsky
    Zucker Inbar
    Chodick Gabriel
    Shalev Varda
    BMC Family Practice, 13
  • [33] A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia
    Makhoul, Elias
    Aklinski, Joseph L.
    Miller, Jesse
    Leonard, Cara
    Backer, Sean
    Kahar, Payal
    Parmar, Mayur S.
    Khanna, Deepesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [34] Antihypertensive Treatment of Patients With Cardiovascular Disease but Without Hypertension
    LaRiccia, Patrick J.
    Morgan, Sherry
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (21): : 2170 - 2171
  • [35] Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus
    Castro, Luisa Lima
    Duarte Lanna, Cristina Costa
    Pinho Ribeiro, Antonio Luiz
    Telles, Rosa Weiss
    CLINICAL RHEUMATOLOGY, 2018, 37 (10) : 2693 - 2698
  • [36] Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus
    Luísa Lima Castro
    Cristina Costa Duarte Lanna
    Antônio Luiz Pinho Ribeiro
    Rosa Weiss Telles
    Clinical Rheumatology, 2018, 37 : 2693 - 2698
  • [37] Prevalence of Obesity, Hypertension, Diabetes, and Metabolic Syndrome and Its Cardiovascular Complications
    Tuck, Michael L.
    Corry, Dalila B.
    CURRENT HYPERTENSION REVIEWS, 2010, 6 (02) : 73 - 82
  • [38] Mixed Dyslipidemia, Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease: Clinical Implications
    Cannon, Christopher P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 5L - 9L
  • [39] Cardiovascular risk control in hypertension and/or dyslipidemia in primary care
    Mainar, AS
    Bobadilla, JF
    Aristegui, R
    VALUE IN HEALTH, 2005, 8 (06) : A105 - A105
  • [40] THE IMPACT OF UNCONTROLLED HYPERTENSION ON CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC SYNDROME
    Tsounis, D.
    Brellas, N.
    Stamos, G.
    Laschos, V.
    Voutsela, D.
    Platoyiannis, D.
    JOURNAL OF HYPERTENSION, 2010, 28 : E483 - E483
12345